DNA Nanobots
PrivateLast Round
Seed
Dec 17, 2025
Total Funding Raised
$3.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
DNA Nanobots operates in Healthcare & Life Sciences and is based in Powell, Ohio. Its latest recorded funding round was a Seed round in December 2025.
DNA Nanobots is a biotechnology company that develops DNA nanotechnology-based solutions for biomedical applications, including targeted cancer drug delivery, vaccine development, and nucleic acid biosensing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DNA Nanobots Comparables
Compare DNA Nanobots with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DoriNano | 89% | |
| Code Biotherapeutics | 85% | |
| GenLumina | 79% |
For institutional investors. Book with your work email.
DNA Nanobots Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 17, 2025 | ||||
| Pre Seed | Jan 24, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
DNA Nanobots Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ohio State Early Investor Network | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Grew 42% QoQ, from 12 to 17 employees.
- Jul 24, 2026
Monthly visitors increased 65% MoM.
For institutional investors. Book with your work email.
DNA Nanobots Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about DNA Nanobots's valuation, stock price, and market status.
Is DNA Nanobots a public or private company?
DNA Nanobots is a private company.
What is the current stock price of DNA Nanobots?
DNA Nanobots is a private company, so its shares have no public market price. Caplight tracks DNA Nanobots's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DNA Nanobots worth (valuation)?
Valuation information for DNA Nanobots is not publicly available.
Can I buy DNA Nanobots stock?
DNA Nanobots shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DNA Nanobots's last funding round?
DNA Nanobots's most recent funding round was Seed on December 17, 2025.
Who are the main investors in DNA Nanobots?
Key investors in DNA Nanobots include Ohio State Early Investor Network.
Will DNA Nanobots IPO soon?
No public IPO plans have been announced for DNA Nanobots.
How can I track DNA Nanobots secondary market activity?
Caplight tracks bids, offers, and trades in DNA Nanobots's shares on secondary markets.